AAPM VL-Radiopharmaceutical Therapy Patient Specific Dosimetry

2021 AAPM Virtual Spring Clinical Meeting - Session: Radiopharmaceutical Therapy Patient Specific Dosimetry - The Why and The How

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.

Quantitative Imaging and Associated Uncertainties in Patient Specific Dosimetry with Radiopharmaceutical Therapies
Yuni Dewaraja, University of Michigan
yuni@med.umich.edu

When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below). add this video to a playlist.

All videos in this session:

	Dosimetry Methodologies and Nomenclature for Radiopharmaceutical Therapy – MIRD and ICRU - Wesley Bolch, University of Florida
	Bio-effect Modeling and Combination Therapy with Radiopharmaceutical Therapies - Robert Hobbs, Johns Hopkins University
	Q&A - Matthew Hough, AdventHealth Orlando
	Q & A -

Graph includes 48 member loads and 371 non-member loads (419 total loads). Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.

AAPM is the American Association of Physicists in Medicine.
1631 Prince Street
Alexandria, VA 22314
Phone 571-298-1300
Fax 571-298-1301 
Send general questions to 2023.aapm@aapm.org

AAPM's Privacy Policy
Use of the site constitutes your acceptance to its terms and conditions.

AAPM is a scientific, educational, and professional nonprofit organization devoted to the discipline of physics in medicine. The information provided in this website is offered for the benefit of its members and the general public, however, AAPM does not independently verify or substantiate the information provided on other websites that may be linked to this site.

AAPM Virtual Library

2021 AAPM Virtual Spring Clinical Meeting - Session: Radiopharmaceutical Therapy Patient Specific Dosimetry - The Why and The How

This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.